Synthetic Route of C10H14N2O. The mechanism of aromatic electrophilic substitution of aromatic heterocycles is consistent with that of benzene. Compound: 4-(Piperazin-1-yl)phenol, is researched, Molecular C10H14N2O, CAS is 56621-48-8, about Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound. Author is Gomes, Tatiana F.; Pompeu, Thais E. T.; Rodrigues, Daniel A.; Noel, Francois; Menegatti, Ricardo; Andrade, Carolina H.; Sabino, Jose R.; Gil, Eric S.; Dalla Costa, Teresa; Betti, Andresa H.; Antonio, Camila B.; Rates, Stela M. K.; Fraga, Carlos A. M.; Barreiro, Eliezer J.; de Oliveira, Valeria.
Using a combination of docking and mol. dynamics simulations, we predicted that p-hydroxylation by CYP1A2 would be the main metabolic pathway for the 1-[1-(4-chlorophenyl)-1H-4pyrazolylmethyl] phenylhexahydropiperazine, LASSBio-579. As the result of a screening process with strains of filamentous fungi, Cunninghamella echinulata ATCC 9244 was chosen to scale up the preparation of the p-hydroxylated metabolite. About 30 min after i.p. administration of LASSBio-579 to rats was identified as the p-hydroxylated metabolite, confirming our in silico previsions. Chem. synthesis of the metabolite was performed and allowed its pharmacol. evaluation in binding assays revealing its high affinity for D2 and D4 receptors, indicating that this metabolite should participate to the antipsychotic effect of LASSBio-579 in vivo. Furthermore, we report here that both LASSBio-579 and its p-hydroxylated metabolite have a much lower affinity than clozapine for two receptors involved in adverse reactions. Voltammetric assays were useful to understand the redox profile of LASSBio-579.
There is still a lot of research devoted to this compound(SMILES：OC1=CC=C(N2CCNCC2)C=C1)Synthetic Route of C10H14N2O, and with the development of science, more effects of this compound(56621-48-8) can be discovered.
Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem